Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00826579 | Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer | completed | Phase 1 / Phase 2 | 192 | University Hospital, Basel, SwitzerlandOTHER | 1 | Mar 12, 2015 | clinicaltrials |
| NCT02295930 | Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient(MACBETH) | completed | Phase 2 | 143 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 12, 2015 |
| clinicaltrials |
| NCT01358812 | FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer(TRIP) | completed | Phase 2 | 37 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01579357 | Pharmacokinetics and Metabolic Activation of Capecitabine | completed | Phase 2 | 24 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01547130 | Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation | completed | Phase 1 / Phase 2 | 133 | Arya, Vijaypal, M.D., P.C.INDIV | 1 | Mar 4, 2015 | clinicaltrials |
| NCT00103311 | SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 2, 2015 | clinicaltrials |
| NCT01135498 | A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 90 | Hoffmann-La RocheINDUSTRY | 1 | Feb 6, 2015 | clinicaltrials |
| NCT00904839 | BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer | completed | Phase 2 | 128 | Boehringer IngelheimINDUSTRY | 5 | Feb 4, 2015 | clinicaltrials |
| NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | completed | Phase 2 | 136 | Yonsei UniversityOTHER | 1 | Jan 28, 2015 | clinicaltrials |
| NCT00660582 | FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor | completed | Phase 2 | 152 | Per PfeifferOTHER | 3 | Jan 21, 2015 | clinicaltrials |
| NCT01483001 | Feasibility Study on Stem Cells Sensitivity Assay(STELLA) | completed | Phase 2 | 23 | Associazione Oncologia TraslazionaleOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT00754494 | Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2015 | clinicaltrials |
| NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | completed | Phase 2 | 75 | Hoffmann-La RocheINDUSTRY | 1 | Dec 15, 2014 | clinicaltrials |
| NCT00865709 | Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects | completed | Phase 2 | 198 | BayerINDUSTRY | 10 | Dec 11, 2014 | clinicaltrials |
| NCT00704600 | Nelfinavir, a Phase I/Phase II Rectal Cancer Study(Nelfinavir) | completed | Phase 1 / Phase 2 | 15 | Maastricht Radiation OncologyOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01472770 | A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer(GemCaP) | completed | Phase 2 | 49 | Vejle HospitalOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT00376909 | A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women | completed | Phase 2 | 2,729 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients(New Beat) | completed | Phase 2 | 25 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01413295 | Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 52 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT01378143 | Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy | completed | Phase 2 | 53 | Oncozyme Pharma Inc.INDUSTRY | 1 | Oct 21, 2014 | clinicaltrials |
| NCT02032485 | Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer(OC-AP-ICG-IV) | completed | Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00589563 | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer | completed | Phase 2 | 32 | City of Hope Medical CenterOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT01525056 | Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI | completed | Phase 2 | 30 | London Health Sciences CentreOTHER | 1 | Sep 9, 2014 | clinicaltrials |
| NCT01186263 | Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy(EXPLOSIVE) | completed | Phase 2 | 24 | University of MagdeburgOTHER | 1 | Sep 4, 2014 | clinicaltrials |
| NCT00416494 | Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer | completed | Phase 2 | 50 | Herbert Hurwitz, MDOTHER | 0 | Sep 3, 2014 | clinicaltrials |
| NCT01159171 | A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT00514761 | Phase II Efficacy Study of AZD6244 in Colorectal Cancer | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Aug 13, 2014 | clinicaltrials |
| NCT00125034 | Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)(OPUS) | completed | Phase 2 | 344 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 13 | Aug 7, 2014 | clinicaltrials |
| NCT01105377 | Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Aug 1, 2014 | clinicaltrials |
| NCT00159432 | Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer | completed | Phase 2 | 63 | University of Southern CaliforniaOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01181609 | A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 54 | Hoffmann-La RocheINDUSTRY | 1 | Jul 28, 2014 | clinicaltrials |
| NCT02198274 | Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 25 | Boehringer IngelheimINDUSTRY | 0 | Jul 23, 2014 | clinicaltrials |
| NCT00393822 | A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | completed | Phase 2 / Phase 3 | 100 | AmgenINDUSTRY | 0 | Jul 15, 2014 | clinicaltrials |
| NCT00044343 | GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin | completed | Phase 2 | 80 | GlaxoSmithKlineINDUSTRY | 2 | Jul 10, 2014 | clinicaltrials |
| NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer(FOLFERA) | completed | Phase 2 | 111 | Cardiff UniversityOTHER | 1 | Jul 8, 2014 | clinicaltrials |
| NCT02181465 | Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma.(CC1A&B) | completed | Phase 2 | 11 | Cancer Advances Inc.INDUSTRY | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00165854 | Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eisai LimitedINDUSTRY | 3 | Jun 27, 2014 | clinicaltrials |
| NCT00439517 | Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.(FUTURE) | completed | Phase 2 | 302 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 14 | Jun 27, 2014 | clinicaltrials |
| NCT00901147 | Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma | completed | Phase 2 | 25 | Singapore General HospitalOTHER | 3 | Jun 27, 2014 | clinicaltrials |
| NCT01152437 | A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 94 | Boehringer IngelheimINDUSTRY | 1 | Jun 26, 2014 | clinicaltrials |
| NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | completed | Phase 2 | 58 | Roswell Park Cancer InstituteOTHER | 1 | Jun 23, 2014 | clinicaltrials |
| NCT01208194 | Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma(IMPACT) | completed | Phase 2 | 59 | Mologen AGINDUSTRY | 6 | Jun 20, 2014 | clinicaltrials |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 17, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01225744 | Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy(eSCOUT) | completed | Phase 2 | 47 | The Christie NHS Foundation TrustOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00675012 | NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 24 | AGC Biologics S.p.A.INDUSTRY | 1 | May 30, 2014 | clinicaltrials |
| NCT00054639 | Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 53 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Mar 12, 2015source: clinicaltrials